When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - Adamas Pharmaceuticals: A Second Inning In Play
Adamas Pharmaceuticals Inc.
More than a year ago, we wrote a series of articles on Adamas Pharmaceuticals (ADMS); in one of these, we said that ADMS is not a one-trick pony and that Gocovri's eventual label expansion in walking impairment in MS patients will be a far bigger revenue-generator than its existing approval in LID in Parkinson's patients. Gocovri (amantadine) is already FDA approved for the treatment of dyskinesia in patients with PD receiving levodopa-based therapy, with or without concomitant dopaminergic medications. Now that Gocovri has completed enrollment in the phase 3 trial in this new